Pilot/Feasibility Study Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Kidney Transplant
- Sponsor
- NYU Langone Health
- Enrollment
- 12
- Locations
- 1
- Primary Endpoint
- Number of Adverse Events
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The objective of this study is to evaluate the feasibility of the MoveMend Health software program as an integrated supplement to traditional acute care/in-hospital occupational therapy for patients following liver and kidney transplants, as determined by recruitment rates, program completion, intervention adherence, safety incidence, and patient feedback on device/program performance.
Investigators
Eligibility Criteria
Inclusion Criteria
- •English speaking (software program is currently only available in English)
- •Status post kidney or liver transplant this admission
- •Physician orders for occupational therapy evaluation and treatment
- •Orientation Log \> 25
- •Negative for delirium per the Confusion Assessment Method
Exclusion Criteria
- •Orthopedic or surgical precautions that limits shoulder range of motion beyond 90 degrees
- •Upper extremity hemiplegia with inability to lift upper extremity against gravity
- •Accommodation code of Intensive Care Unit
Outcomes
Primary Outcomes
Number of Adverse Events
Time Frame: Up to Month 6 Post-Operation
Measured using data from participant's electronic medical record.
Percentage of Participants who Adhere to Intervention
Time Frame: Up to Month 6 Post-Operation
Measured by session duration and frequency, as recorded by the device. Participants will be classified as "adhering" or "not adhering."
Recruitment Rate
Time Frame: Up to Month 6 Post-Operation
Calculated by dividing the number of participants enrolled by the total number of patients contacted or screened.
Percentage of Participants who Complete Exercise Program
Time Frame: Up to Month 6 Post-Operation
Percentage of enrolled participants who complete the interventional program.
Secondary Outcomes
- Change in Activity Measure for Post-Acute Care (AMPAC) Score(Baseline, End of Hospital Stay (typically no more than 6 months post-operation))
- Change in EuroQol 5-Dimension 5-Level (EQ-5D-5L) Questionnaire Index Score(Baseline, End of Hospital Stay (typically no more than 6 months post-operation))
- Upper Extremity Range of Motion (ROM) Change(Baseline, End of Hospital Stay (typically no more than 6 months post-operation))
- Change in Grip Strength(Baseline, End of Hospital Stay (typically no more than 6 months post-operation))